Overview
Tomoyo Kubo practices in Kobe, Japan. Their top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Lymphofollicular Hyperplasia, Autoimmune Hemolytic Anemia, and Follicular Lymphoma.
Their clinical research consists of co-authoring 8 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Autoimmune Hemolytic AnemiaKubo isExperienced. Learn about Autoimmune Hemolytic Anemia.
- Chronic Graft Versus Host Disease (cGvHD)
- COVID-19Kubo isExperienced. Learn about COVID-19.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Follicular LymphomaKubo isExperienced. Learn about Follicular Lymphoma.
- Lymphofollicular Hyperplasia